SCHEMBL7902298

SCHEMBL7902298

O=C(C1=CC=C(c2ccc(F)cc2)CC1)N1CCC(C(=O)NNc2ccccn2)(c2ccc(F)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.41
ALDH1A1 P00352 2/20 0.38
HTT P42858 1/20 0.38
GAA P10253 2/20 0.37
KDM4E B2RXH2 1/20 0.37
IDO1 P14902 1/20 0.37
HSD11B1 P28845 4/20 0.36
KMT2A Q03164 1/20 0.35
SLC6A7 Q99884 1/20 0.35
PKM P14618 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNA1C Q13936 1/20 0.34
HTR1A P08908 1/20 0.33
ADRA1A P35348 1/20 0.33
PRKAA2 P54646 1/20 0.33
GRM5 P41594 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13092423 0.85 SLC6A7 (0.50) P2RX7ALDH1A1HTTGAAKDM4E
SCHEMBL7900933 0.85 P2RX7 (0.37) P2RX7ALDH1A1GAAIDO1HSD11B1
SCHEMBL7908417 0.73 KIT (0.40) ALDH1A1HTTKMT2ACACNA1HCYP3A4
SCHEMBL28595853 0.70 ALDH1A1 (0.66) P2RX7ALDH1A1HTTGAAKDM4E
SCHEMBL7907727 0.70 SLC6A7 (0.50) HSD11B1KMT2ASLC6A7PRKAA2CYP3A4
SCHEMBL3107003 0.69 PTPN1 (0.50) P2RX7HSD11B1KMT2ASLC6A7PRKAA2
SCHEMBL28593421 0.68 HTT (0.75) P2RX7ALDH1A1HTTGAAKDM4E
SCHEMBL7914034 0.67 SLC6A7 (0.47) ALDH1A1HTTGAAIDO1HSD11B1
SCHEMBL3227686 0.66 CYP3A4 (0.48) P2RX7ALDH1A1KMT2ASLC6A7CYP3A4
SCHEMBL7900928 0.65 PTPN1 (0.46) ALDH1A1HTTHSD11B1KMT2ASLC6A7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010106081-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-23 WO disclosed